4
Changes in Ownership
Teladoc Health, Inc. Filed Acc 0001179110-20-005666
Chief Executive Officer sold 40,000 shares at $170.26 ($6,810,400)
- Chief Executive Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| GOREVIC JASON N Chief Executive Officer | 2020-05-05 | Option exercise | +20,000 | $1.67 | $33,400 | 711,283 | D: show line 1 in the form |
| GOREVIC JASON N Chief Executive Officer | 2020-05-05 | Sale | −40,000 | $170.26 | $6,810,400 | 671,283 | D: show line 2 in the form |
| Open-market sales · 40,000 sh · avg $170.26 · $6,810,400 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| GOREVIC JASON N Chief Executive Officer | 2020-05-05 | Option exercise · Employee Stock Option (right to buy) | −20,000 | 23,067 | D: show line 3 in the form |
Loading xslF345X03/edgar.xml…